Study Conduct

Two researches charged with falsifying clinical data

Friday, June 3, 2011 01:52 PM

Two former employees of Kansas-based Lee Research Institute have been indicted for falsifying study data in a clinical trial, according to a report in the Kansas City Business Journal.

More... »


MaRS Innovation, GlaxoSmithKline partner to accelerate translational research

Tuesday, May 31, 2011 03:37 PM

MaRS Innovation (MI) and GlaxoSmithKline (GSK) have announced a new development fund—the GSK-MaRS Innovation Fund—to support and fast-track the commercialization of some of Canada’s most promising translational research coming from 16 leading academic health sciences centers, hospitals and universities derived from the MI membership.

More... »


Sanofi, DNDi collaborate on new drugs for neglected tropical diseases

Tuesday, May 31, 2011 03:35 PM

French health care company Sanofi has announced a three-year research collaboration agreement with Drugs for Neglected Diseases initiative or DNDi, an independent, nonprofit product development partnership, according to RTT News.

More... »

NIHR Clinical Research Network studies hit record high

Tuesday, May 31, 2011 03:32 PM

The number of commercial studies adopted into the National Institute for Health Research’s Clinical Research Network (NIHR CRN) Portfolio in England during the third quarter of 2010-2011 reached 115, the highest level since the network started compiling quarterly reports in 2008, according to PharmaTimes.

More... »

Launch of Encore site network could signal beginning of consolidation wave in site sector

Tuesday, May 31, 2011 09:40 AM

Some notable shifts are afoot in the site sector of the clinical trials industry.

More... »

PharmaNet Canada to partner with HMR

Friday, May 27, 2011 11:51 AM

PharmaNet Development Group, a provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, announced that its subsidiary, PharmaNet Canada, and Maisonneuve-Rosemont  Hospital (HMR) and its research center, will collaborate to conduct pharmacokinetic studies in patients with impaired renal function.

More... »

Pfizer's rheumatoid arthritis pill impresses experts despite study deaths

Wednesday, May 25, 2011 12:31 PM

Pfizer's new rheumatoid arthritis pill impressed experts at a medical meeting in London today, despite four deaths in a study that spooked investors last month, according to Reuters.

More... »

Leeds Cancer Research sees 2,000 trial participants

Wednesday, May 25, 2011 11:57 AM

More than 2,000 cancer patients have signed up for clinical trials at the Leeds Cancer Research U.K. Center since its official opening last year, according to a report on BioscienceTechnology.com.

More... »

JaxResearch, Inclinix launch Encore site group

Monday, May 23, 2011 08:55 AM

Jacksonville, Fla.-based site group JaxResearch Systems and Wilmington, N.C.-based recruiting company Inclinix together are launching a new site group called Encore Integrated Clinical Research.  

More... »

Quintiles’ Chasse, Sanofi Pasteur’s Milam make unprecedented industry move to the site world

Monday, May 23, 2011 08:44 AM

Christine Pierre, president of the investigator site group and consultancy RxTrials, shocked parts of the industry this month when she hired Adam Chasse away from global CRO Quintiles and Dan Milam from Sanofi Pasteur, the largest company in the world devoted to vaccines.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

February 25

Analysts: With market anticipation of Quintiles IPO, other CROs could soon file to go public

National Clinical Trial Network aims to link sponsors, minority patients for trials and access to new therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Sites rate the best
sponsors of 2013

Largest survey response ever puts Biogen Idec, Forest Labs, Bayer at top

As CRO industry
turns 30, a look back
at modest beginnings

Phenomenal growth, strategic partnering highlight evolution
of CROs

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Sized out of big deals,
mid-tier CROs still thriving

Finding market niches, strategies to stay vital in changing research enterprise

Industry leaders embrace disruptive innovations
Despite resistance to change, many exploring data sharing, open-source collaboration

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs